Financials in USD. Standardized financial statements.
A compact view of how CompuGroup Medical SE & Co. KGaA turns revenue into operating income and net income.
| Metric | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue? | $1.15B | $1.19B | $1.13B | $1.03B | $837.26M | $745.81M | $717.02M | $582.38M | $560.20M | $543.07M |
| Revenue Growth? | -2.8% | +5.1% | +10.2% | +22.5% | +12.3% | +4.0% | +23.1% | +4.0% | +3.2% | 0.0% |
| Cost of Revenue? | $188.84M | $182.61M | $171.58M | $154.13M | $124.31M | $114.39M | $132.92M | $90.34M | $94.04M | $90.90M |
| Gross Profit? | $965.14M | $1.01B | $958.16M | $871.19M | $712.95M | $631.42M | $584.11M | $492.03M | $466.15M | $452.17M |
| Gross Margin? | +83.6% | +84.6% | +84.8% | +85.0% | +85.2% | +84.7% | +81.5% | +84.5% | +83.2% | +83.3% |
| Operating Expenses? | $859.40M | $1.01B | $850.70M | $763.29M | $587.59M | $516.16M | $444.59M | $404.89M | $387.45M | $385.97M |
| Operating Income? | $105.74M | $122.10M | $125.61M | $108.69M | $119.67M | $112.28M | $137.24M | $70.60M | $80.32M | $72.29M |
| EBITDA? | $206.90M | $212.79M | $228.25M | $213.99M | $192.49M | $176.28M | $185.11M | $111.43M | $126.74M | $116.83M |
| Income Before Tax | $61.89M | $72.67M | $106.82M | $97.87M | $110.43M | $107.75M | $128.75M | $65.56M | $74.21M | $62.20M |
| Income Tax Expense | $27.13M | $25.80M | $32.70M | $28.84M | $37.01M | $41.59M | $36.16M | $33.81M | $29.74M | $23.58M |
| Net Income? | $34.60M | $45.92M | $73.41M | $68.97M | $73.19M | $65.82M | $92.34M | $31.25M | $44.53M | $38.49M |
| EPS? | $0.67 | $0.88 | $1.41 | $1.32 | $1.36 | $1.36 | $1.88 | $0.63 | $0.90 | $0.77 |
| Diluted EPS? | $0.67 | $0.88 | $1.40 | $1.30 | $1.36 | $1.33 | $1.85 | $0.63 | $0.90 | $0.77 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality